Latest articles
JNJ Johnson & Johnson Reports Q3 Beat, Raises Outlook
Oct. 17, 2023, 3:18 p.m.

Sentiment statistics ?
Financial Histories
Please use our Financial history templates to chart, read and compare all 10'Q filings in depth.
Overview
JNJDay performance
JNJ | |
---|---|
Price | 152.50 |
Change Pct | 1.11 |
Change Abs | 1.68 |
Market Cap | 367.1 billion |
Eps | 5.34 |
Pe Ratio | 28.56 |
Outstanding Shares | 2.4 billion |
Volume | 3.4 million |
Avg Volume | 7.3 million |
Industry | Drug Manufacturers—General |
Sector Name | Health Care |
Country Short Name | null |
Announcement Earnings | 2024-01-23 10:59:00+00:00 |
Risk Profiles
Please sign up and become a member to view all risk profiles.
Peers
Focus
Use our 'Focus' approach as text-and chart based summaries of the financial standing for a company. They are solely focussing on the company's market, risks and chances.
Company descriptions
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.